Luis Moreno Sánchez

Oncólogo Radioterápico y Médico Nuclear | Hospital Metropolitano de Santiago - HOMS | Director de Radioterapia

[Luis Moreno Sánchez @drluismorenos]

Migraine

https://t.co/G96T0MIQhe

[Luis Moreno Sánchez @drluismorenos]

Impact of structured reporting on interpretability of PSMA PET/CT in prostate cancer staging—towards standardised clinical implementation.

https://t.co/4GhuzhtNMm

[Luis Moreno Sánchez @drluismorenos]

EQD2 In modern cervix HDR brachytherapy: Clinical utility, sources of uncertainty, and interpretation
https://t.co/YBSGYDnhVP

[Luis Moreno Sánchez @drluismorenos]

Hypofractionated 44 Gy in 20 fractions versus conventional chemoradiation in cervical cancer: 2-year results of the randomized HYPOCx-iRex trial with an exploratory pooled analysis of a single-institute EMBRACE-II cohort

https://t.co/JyuL0EDyZm

[Luis Moreno Sánchez @drluismorenos]

LINACS: a living systematic review of the safety of concurrent stereotactic radiotherapy and novel systemic therapies by the ESTRO/EORTC OligoCare Consortium.

https://t.co/oXUZer1kUj
@RO_GreenJournal

[Luis Moreno Sánchez @drluismorenos]

Carcinoma of unknown primary (CUP) of the head and neck: state of the art and future perspectives.

https://t.co/VVfU1viYkN

[Luis Moreno Sánchez @drluismorenos]

Implications for clinical practice in diagnostic imaging, interventional radiology and diagnostic nuclear medicine, second edition.
https://t.co/GI2utTilHr

[Luis Moreno Sánchez @drluismorenos]

Total neoadjuvant therapy for rectal cancer: where are we now, where do we go?

https://t.co/Ed1o9Z93da

[Luis Moreno Sánchez @drluismorenos]

⏱️ En oncología, el tiempo también forma parte del tratamiento.

Detectar un cáncer tempranamente representa una gran oportunidad, pero su beneficio puede disminuir si existen retrasos innecesarios en la confirmación diagnóstica, la estadificación o el inicio de la terapia.

Durante la espera, algunos tumores pueden crecer, progresar o perder una ventana terapéutica favorable. Por eso es fundamental:

🔹 Agilizar los estudios diagnósticos.
🔹 Realizar una evaluación multidisciplinaria oportuna.
🔹 Respetar los tiempos oncológicos.
🔹 Garantizar acceso temprano a cirugía, radioterapia y tratamientos sistémicos.
🔹 Evitar demoras administrativas o asistenciales prevenibles.

Cada cáncer tiene un comportamiento diferente y requiere una planificación individualizada. Sin embargo, actuar con coordinación, calidad y oportunidad puede contribuir a mejorar el control de la enfermedad, la supervivencia y la calidad de vida.

Diagnosticar a tiempo es esencial. Tratar a tiempo puede marcar la diferencia.

Bibliografía: Dixon L.K et al. Curative-Intent Radiotherapy in the Era of Earlier Lung Cancer Diagnosis: Insights from the National Lung Cancer Audit. Clinical Oncology 58 (2026) 104309.

[Luis Moreno Sánchez @drluismorenos]

Tumor Lysis Syndrome

https://t.co/9z39IzQDIb

[Luis Moreno Sánchez @drluismorenos]

Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC).

https://t.co/QXttpOhBFg

[Luis Moreno Sánchez @drluismorenos]

How can children benefit from total-body PET?

https://t.co/SBUfJ8PtNr

[Luis Moreno Sánchez @drluismorenos]

Nuclear medicine in paediatric tumours: current status and focus on theranostics.

https://t.co/V6V8ez9sra

[Luis Moreno Sánchez @drluismorenos]

Highly conformal whole abdominopelvic radiotherapy: Consensus delineation guidelines from EpSSG and QUARTET

https://t.co/VeI53prpNd

@RO_GreenJournal

[Luis Moreno Sánchez @drluismorenos]

Emergencies in Hematology: Why, When and How I Treat?

https://t.co/zraXpnCqvt

[Luis Moreno Sánchez @drluismorenos]

Comparative efficacy of stereotactic body radiotherapy and percutaneous radiofrequency ablation for oligometastatic liver disease—radiation oncologists’ perspective and practice guideline

https://t.co/ZMpOOWNfBt

[Luis Moreno Sánchez @drluismorenos]

Nuclear medicine in the operating room: present and future

https://t.co/JmQXVMZrjO

[Luis Moreno Sánchez @drluismorenos]

How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice
consensus recommendations

https://t.co/AfmfOhDxpr

@RO_GreenJournal @ElsevierConnect

[Luis Moreno Sánchez @drluismorenos]

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I

https://t.co/M2JsBqwAU7

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update

https://t.co/JNfephHD5E

[Luis Moreno Sánchez @drluismorenos]

Diagnosis and management of neutropenia in adults: Expert guidance

https://t.co/8e8kQOB9QI